Clinical Trial Update: Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Technosphere Inhalation Insulin (TI) using the Gen2 inhaler in Type 2 diabetes was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Technosphere Inhalation Insulin (insulin inhalation powder)

Snippet

Sponsor: Mannkind Corporation | Conditions: Type 2 Diabetes | Phase 3 | Status: TERMINATED | Results posted: 2014-10-21